These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1620191)

  • 41. The effects of drug abuse on pregnancy.
    Kuczkowski KM
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):578-85. PubMed ID: 18007137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cocaine babies in Oklahoma.
    Giacoia GP
    J Okla State Med Assoc; 1990 Feb; 83(2):64-7. PubMed ID: 2308022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The care of infants menaced by cocaine abuse.
    Lewis KD; Bennett B; Schmeder NH
    MCN Am J Matern Child Nurs; 1989; 14(5):324-9. PubMed ID: 2507857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Birth outcomes, health problems, and neglect with prenatal exposure to cocaine.
    Kelley SJ; Walsh JH; Thompson K
    Pediatr Nurs; 1991; 17(2):130-6. PubMed ID: 1712934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A treatment team at the Huddinge Hospital helps pregnant addicts. Interview by Eva Oldinger].
    Larsson G; Ottenblad C; Rydberg U
    Nord Med; 1982 Jan; 97(1):9-10. PubMed ID: 7058118
    [No Abstract]   [Full Text] [Related]  

  • 46. Statement on drug use in pregnancy: an urgent problem for New York City. Committee on Public Health. The New York Academy of Medicine.
    Bull N Y Acad Med; 1990; 66(2):193-7. PubMed ID: 2364214
    [No Abstract]   [Full Text] [Related]  

  • 47. Smoking patterns and outcomes in a population of pregnant women with other substance use disorders.
    Burns L; Mattick RP; Wallace C
    Nicotine Tob Res; 2008 Jun; 10(6):969-74. PubMed ID: 18584460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Maternal cocaine use: impact on child health and development.
    Frank DA; Bresnahan K; Zuckerman BS
    Adv Pediatr; 1993; 40():65-99. PubMed ID: 8249714
    [No Abstract]   [Full Text] [Related]  

  • 49. [Drugs and pregnancy].
    Halmesmäki E; Kari A
    Duodecim; 1998; 114(20):2109-14. PubMed ID: 11717737
    [No Abstract]   [Full Text] [Related]  

  • 50. Cough mixture abuse in pregnancy, folate deficiency, and neural tube defects?
    Tsang SK; Au WY
    Am J Hematol; 2005 Feb; 78(2):163. PubMed ID: 15682424
    [No Abstract]   [Full Text] [Related]  

  • 51. Illicit drug use and neonatal outcomes: a critical review.
    Schempf AH
    Obstet Gynecol Surv; 2007 Nov; 62(11):749-57. PubMed ID: 17925048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Illicit drugs and surgery.
    Hall AP; Henry JA
    Int J Surg; 2007 Oct; 5(5):365-70. PubMed ID: 17933696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influencing physician response to prenatal substance exposure through state legislation and work-place policies.
    Zellman GL; Jacobson PD; Bell RM
    Addiction; 1997 Sep; 92(9):1123-31. PubMed ID: 9374009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pregnancy and drug addiction.
    Fraser A
    Midwife Health Visit Community Nurse; 1978 May; 14(5):132-5. PubMed ID: 247185
    [No Abstract]   [Full Text] [Related]  

  • 55. Compensating for deficiencies in perinatal data sets: parametric perspectives.
    Tippetts AS; Marques PR
    NIDA Res Monogr; 1996; 166():272-91. PubMed ID: 8818178
    [No Abstract]   [Full Text] [Related]  

  • 56. Methodological issues in epidemiological, prevention, and treatment research on drug-exposed women and their children. Technical review meeting. Baltimore, Maryland, July 25-26, 1990.
    NIDA Res Monogr; 1992; 117():1-393. PubMed ID: 1620190
    [No Abstract]   [Full Text] [Related]  

  • 57. Qualitative methodological issues in drug user research.
    Valdez A; Sifaneck SJ
    Subst Use Misuse; 2010 Apr; 45(5):645-7. PubMed ID: 20222776
    [No Abstract]   [Full Text] [Related]  

  • 58. Who is it going to be? Subject selection issues in prenatal drug exposure research.
    Fried PA
    NIDA Res Monogr; 1992; 117():121-36. PubMed ID: 1620191
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies of prenatal drug exposure and environmental research issues: the benefits of integrating research within a treatment program.
    Kaltenbach KA; Finnegan LP
    NIDA Res Monogr; 1992; 117():259-70. PubMed ID: 1620201
    [No Abstract]   [Full Text] [Related]  

  • 60. How the environment affects research on prenatal drug exposure: the laboratory and the community.
    Coles CD
    NIDA Res Monogr; 1992; 117():271-92. PubMed ID: 1620202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.